Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
The facility has the capacity to produce one crore doses per day
First diagnostic centre to open in Mohali on August 31
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y
The Endosonography allows the use of EUS guided Fine needle aspiration for accurate diagnosis of GI cancers without the need for conventional biopsies
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
National Institute of Animal Biotechnology, Hyderabad can now conduct quality checks and consequent lot release of Covid-19 vaccines
Subscribe To Our Newsletter & Stay Updated